Jaundice News and Research

RSS

Jaundice, also known as icterus (attributive adjective: icteric), is a yellowish discoloration of the skin, the conjunctival membranes over the sclerae (whites of the eyes), and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood).

Hepatitis A outbreak among population of San Diego

The San Diego population is facing one of the worst outbreaks of infective viral disease Hepatitis A. the outbreak began last November and is still going strong with no signs of reduction in the infection rates. The homeless are one of the worst hit.

3 Sep 2017

Smartphone app could be used to screen for pancreatic cancer

Scientists have created an app that uses Smartphone selfies to detect pancreatic cancer while it is in the early stages.

29 Aug 2017

New app could lead to earlier detection of pancreatic cancer by snapping a smartphone selfie

Pancreatic cancer has one of the worst prognoses -; with a five-year survival rate of 9 percent -; in part because there are no telltale symptoms or non-invasive screening tools to catch a tumor before it spreads.

29 Aug 2017

Research finds how omega-3 supplements dampen harmful inflammatory reactions

OMEGA-3: Omega-3 fatty acids, which we primarily get through eating fatty fish, have long been thought to be good for our health.

23 Aug 2017

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Collaborative effort to develop rare disease patient registries

The Orphan Disease Center in the Perelman School of Medicine at the University of Pennsylvania will collaborate with Pulse Infoframe Inc., a medical informatics company, to develop rare disease patient registries aimed at enabling international collaboration to better understand these diseases, as well as accelerate and improve clinical studies to develop new therapies.

31 May 2017

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants.

8 May 2017

Skin-to-skin contact and breastfeeding instigate bonding between mothers and newborns

When little Aiden Sandoval was born, lactation consultant Delia Peña was in the birthing suite ready to place him against his mother's bare chest.

21 Apr 2017

KU Leuven-led consortium to develop new vaccine that protects against rabies and yellow fever

Rabies and yellow fever claim ten thousands of lives each year. Vaccines already exist but various drawbacks that hinder their efficient distribution.

4 Apr 2017

Study could provide novel therapeutic approach for preventing severe jaundice in newborn babies

For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.

6 Feb 2017

Penn researchers shed new light on potential causes of premature birth

Depending on the specific type, bacteria in a woman's vagina and cervix may increase the risk of premature birth or protect against it, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

27 Jan 2017

Cervicovaginal microbial communities in pregnant woman may be key to preventing preterm birth

A team of researchers that has confirmed the presence of bacteria in a woman's vagina and cervix may either increase the risk of premature birth or have a protective effect against it, has won the March of Dimes Award for Best Abstract on Prematurity at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting. The findings will be presented Thursday, January 26, at 1:15 p.m. PST at Caesars Palace Augustus Ballroom in Las Vegas.

24 Jan 2017

Accurate test for jaundice could lead to effective treatment in premature newborns

Seeking to improve the care of preterm infants, a new study by researchers at Rutgers Robert Wood Johnson Medical School has found a more accurate test for jaundice, a common disorder in newborns.

17 Jan 2017

Novel treatment can effectively inhibit development of GVHD in mice, study shows

Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants.

12 Jan 2017

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy

10 Nov 2016

Pancreatic cancer to become third leading cause of death in the EU in 2017

The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.

7 Nov 2016